Passage Bio, Inc.
NASDAQ:PASG
7.1799 (USD) • At close September 5, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 3.212 | 0 | 0 | 0 | 5.912 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.2 | 0.201 | 0.719 | 0.8 | 0.8 | 0.806 | 0.807 | 1 | 0.978 | 0.978 | 0.946 | 0.929 | 0.921 | 0.883 | 0.669 | 0.46 | 0.203 | 0.211 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.2 | -0.201 | 1.606 | -0.8 | -0.8 | -0.806 | 5.105 | -1 | -0.978 | -0.978 | -0.946 | -0.929 | -0.921 | -0.883 | -0.669 | -0.46 | -0.203 | -0.211 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0.5 | 0 | 0 | 0 | 0.863 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 5.814 | 7.737 | 9.558 | 8.656 | 10.43 | 11.535 | 12.161 | 15.098 | 17.324 | 16.836 | 17.657 | 15.362 | 26.821 | 26.213 | 32.968 | 26.623 | 33.112 | 24.97 | 27.932 | 20.837 | 19.902 | 13.117 | 9.972 | 10.434 | 6.299 | 3.033 | 5.941 |
| General & Administrative Expenses
| 4.52 | 6.085 | 4.712 | 7.251 | 6.51 | 6.515 | 6.285 | 8.184 | 8.064 | 19.047 | 10.587 | 10.664 | 12.991 | 15.099 | 17.192 | 14.978 | 15.422 | 12.464 | 10.124 | 7.793 | 7.402 | 4.795 | 3.62 | 1.209 | 0.968 | 1.154 | 0.481 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | -0.807 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 4.52 | 6.085 | 4.712 | 7.251 | 6.51 | 6.515 | 5.478 | 8.184 | 8.064 | 19.047 | 10.587 | 10.664 | 12.991 | 15.099 | 17.192 | 14.978 | 15.422 | 12.464 | 10.124 | 7.793 | 7.402 | 4.795 | 3.62 | 1.209 | 0.968 | 1.154 | 0.481 |
| Other Expenses
| 0 | -0.201 | 0.806 | 4.795 | 0.438 | 0 | 0.807 | 5.39 | 1.532 | 1.545 | 0 | 0.825 | 0.27 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 10.334 | 13.621 | 15.076 | 20.702 | 17.378 | 18.05 | 18.446 | 28.672 | 25.388 | 35.883 | 28.244 | 26.026 | 39.812 | 41.312 | 50.16 | 41.601 | 48.534 | 37.434 | 38.056 | 28.63 | 27.304 | 17.912 | 13.592 | 11.643 | 7.267 | 4.187 | 5.819 |
| Operating Income
| -10.334 | -16.459 | -14.27 | -20.702 | -17.378 | -18.05 | -18.446 | -28.672 | -25.388 | -35.883 | -28.244 | -27.526 | -39.812 | -42.812 | -51.16 | -47.101 | -48.534 | -38.934 | -39.056 | -28.63 | -27.304 | -17.912 | -13.592 | -11.643 | -7.767 | -4.187 | -6.422 |
| Operating Income Ratio
| 0 | 0 | -4.443 | 0 | 0 | 0 | -3.12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.949 | 1.054 | 1.545 | 1.362 | 1.387 | 1.339 | 1.688 | 1.562 | 1.532 | 1.545 | 1.173 | 0.825 | 0.27 | 0.001 | 0.006 | 0.186 | 0.099 | 0.052 | 0.112 | 0.099 | 0.132 | 0.327 | 0.441 | 0.255 | -5.659 | -3.482 | 0.603 |
| Income Before Tax
| -9.385 | -15.405 | -12.725 | -19.34 | -15.991 | -16.711 | -16.758 | -27.11 | -23.856 | -34.338 | -27.071 | -26.701 | -39.542 | -42.811 | -51.154 | -46.915 | -48.435 | -38.882 | -38.944 | -28.531 | -27.172 | -17.585 | -13.152 | -11.388 | -13.426 | -7.669 | -5.819 |
| Income Before Tax Ratio
| 0 | 0 | -3.962 | 0 | 0 | 0 | -2.835 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.545 | -1.173 | 0 | -0.27 | -0.001 | -0.006 | -0.186 | -0.099 | 0 | -0.112 | -0.099 | -0.132 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -9.385 | -15.405 | -12.725 | -19.34 | -15.991 | -16.711 | -16.758 | -27.11 | -23.856 | -32.793 | -25.898 | -26.701 | -39.272 | -42.81 | -51.154 | -46.915 | -48.435 | -38.882 | -38.944 | -28.531 | -27.172 | -17.585 | -13.151 | -11.388 | -13.426 | -7.669 | -5.819 |
| Net Income Ratio
| 0 | 0 | -3.962 | 0 | 0 | 0 | -2.835 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -2.96 | -4.96 | -4.1 | -6.26 | -5.18 | -5.94 | -6.1 | -9.9 | -8.8 | -12 | -9.4 | -9.8 | -14.4 | -15.8 | -19 | -17.4 | -18 | -15.2 | -17 | -12.6 | -12 | -20 | -11 | -9.6 | -11.2 | -6.4 | -4.8 |
| EPS Diluted
| -2.96 | -4.96 | -4.1 | -6.26 | -5.18 | -5.94 | -6.1 | -9.9 | -8.8 | -12 | -9.4 | -9.8 | -14.4 | -15.8 | -19 | -17.4 | -18 | -15.2 | -17 | -12.6 | -12 | -20 | -11 | -9.6 | -11.2 | -6.4 | -4.8 |
| EBITDA
| -10.334 | -13.621 | -13.551 | -15.148 | -16.143 | -17.244 | -17.639 | -22.324 | -24.41 | -34.905 | -27.298 | -25.097 | -38.891 | -40.429 | -49.491 | -41.141 | -48.331 | -37.223 | -37.778 | -28.355 | -27.106 | -17.863 | -13.547 | -11.602 | -7.231 | -4.175 | 0.603 |
| EBITDA Ratio
| 0 | 0 | -4.219 | 0 | 0 | 0 | -2.984 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |